Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Thalassemia Screening by Third Generation Sequencing (TGS): Pilot Study in Thai Population

NCT05552690 is registered in ClinicalTrials.gov with Chiang Mai University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05552690 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Thalassemia Screening by Third Generation Sequencing (TGS): Pilot Study in Thai Population
Lead sponsor
Chiang Mai University
Phase
Not applicable
Overall status
Unknown status
Start date
February 1, 2022
Completion date
May 31, 2023
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

thalassemia trait, thalassemia; mixed